tirzepatide + glycine + b12 Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity glycine and b12 injections Lilly

Transdermal-specific considerations for patches would include: Local skin reactions (erythema, itching, irritation at application site) Contact dermatitis from adhesive components or penetration enhancers Skin integrity concerns requiring regular site rotation Patient safety advice for anyone using GLP-1 therapy includes: Report persistent severe abdominal pain (potential pancreatitis) Monitor for signs of gallbladder problems (right upper quadrant pain, particularly after meals) Maintain adequate hydration, especially if experiencing vomiting or diarrhoea Contact your GP if side effects are severe, persistent, or concerning Report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) Regarding pregnancy and breastfeeding, advice varies by product

Diarrhea, constipation, and decreased appetite are also frequently reported

Enhanced Recovery Capacity Users experience dramatically reduced recovery times between workouts or physical therapy sessions, allowing for more frequent and intense training stimulus

Jumping to a high dose too quickly can overwhelm your system, leading to more pronounced and uncomfortable side effects, which can be discouraging and make it difficult to continue treatment

Diarrhea: This side effect is like a sudden rainstorm that can dampen any Hollywood premiere, but patients can manage it by staying hydrated and eating a balanced diet that's high in fiber

And this would be a big one if we see an increase in fertility because we dont actually know the safety of these medications during pregnancy